Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Operating Margin (2016 - 2025)

BioCorRx's Operating Margin history spans 15 years, with the latest figure at 306.28% for Q3 2025.

  • For Q3 2025, Operating Margin changed N/A year-over-year to 306.28%; the TTM value through Sep 2025 reached 571.74%, up 1754831.0%, while the annual FY2024 figure was 66829.81%, 6258150.0% down from the prior year.
  • Operating Margin for Q3 2025 was 306.28% at BioCorRx, up from 793.28% in the prior quarter.
  • Across five years, Operating Margin topped out at 306.28% in Q3 2025 and bottomed at 33852.95% in Q2 2024.
  • The 5-year median for Operating Margin is 5481.4% (2022), against an average of 8836.26%.
  • The largest annual shift saw Operating Margin crashed -2903044bps in 2024 before it skyrocketed 3305968bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 9790.91% in 2021, then skyrocketed by 85bps to 1430.79% in 2022, then plummeted by -204bps to 4344.24% in 2023, then plummeted by -679bps to 33852.95% in 2024, then soared by 99bps to 306.28% in 2025.
  • Per Business Quant, the three most recent readings for BICX's Operating Margin are 306.28% (Q3 2025), 793.28% (Q2 2025), and 695.29% (Q1 2025).